Aug 11, 2020
Pfizer Inc. and Eli Lilly and Company are pleased to announce the call for proposals for the 3rd Global Awards for Advancing Chronic Pain Research (ADVANCE), an independently-reviewed, competitive grants program. The Global Awards for Advancing Chronic Pain Research...
Jun 25, 2020
The European Pain Federation EFIC and the Pfizer-Lilly Alliance are collaborating to offer a new grant opportunity focusing on life-long learning and implementation of education in pain from osteoarthritis. The intention of the project is to encourage an increased...
Apr 23, 2020
The EFIC COVID-19 Task Force was created after realizing the need for news related to COVID-19 being distributed and shared with our community which is looking for advice with regards to pain treatment of their patients. The intended outcome is to distribute relevant...
Feb 14, 2020
The EFIC-Grünenthal-Grant (E-G-G) is now accepting applications. Early-career scientists from across Europe can submit their innovative research projects in the area of chronic pain to be considered for a research grant from this prestigious scheme. How does it work?...
Dec 15, 2019
Why this paper? Pain is a common symptom in patients who survive cancer and in those who live with progressive advanced disease. Evidence from meta‐analyses suggests that pain remains poorly controlled for a large proportion of patients; barriers to good management...
Dec 13, 2019
In February 2020, the EFIC-Grünenthal Grant (E-G-G) will reopen applications for its pain research grant worth a total of €200,000. E-G-G is a research grant scheme awarded by the European Pain Federation EFIC and sponsored by the pharmaceutical company Grünenthal...
